XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | nl | no | nz | pt | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Realm US

18,400 resources

By Version

R2: 0
R2B: 0
R3: 524
R4: 17,438
R4B: 0
R5: 438
R6: 0

By Authority

none: 1,998
hl7: 16,400
national: 2

Start Prev Rows 6600 - 6800 Next

Package	Version	Identity	Name/Title	Status	Date	Auth
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.806	Osteoarthritis of right knee I10	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.807	Osteoarthritis of left knee I10	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.808	Osteoarthritis of right knee	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.809	Osteoarthritis of left knee	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.810	Hip Osteoarthritis SCT	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.811	Hip Osteoarthritis I10	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.812	Hip Osteoarthritis	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.813	Hip joint surgery CPT	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.814	Hip joint surgery SCT	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.815	Hip joint surgery	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.816	Osteoarthritis of right hip I10	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.817	Osteoarthritis of left hip I10	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.818	Osteoarthritis of right hip SCT	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.819	Osteoarthritis of left hip SCT	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.820	Osteoarthritis of right hip	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.821	Osteoarthritis of left hip	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.823	Aminoglycosides	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.824	Carbapenems	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.826	Monobactams	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.827	Penicillins	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.828	Antimycobacterials	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.829	Beta_lactamase	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.830	Cyclic lipopeptides	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.831	Lincosamides	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.832	Macrolides	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.833	Amphenicol	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.834	Oxazolidinones	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.835	Fluoroquinolones	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.836	Sulfonamides	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.837	Tetracyclines	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.838	Phosphonics	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.839	Pleuromutilin	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.840	Streptogramins	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.841	Lipoglycopeptides	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.842	Nitroimidazoles	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.843	PIM_Hyd_Bus_Mir_Tra	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.844	Nitrofurans	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.845	Rifamycins	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.846	Glycylcycline	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.847	Pyrimidines	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.849	Antibiotics oral and parenteral	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.850	Medications_hyperkalemia	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.852	Hyperkalemia_ICD10	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.853	Hyperkalemia_SCT	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.854	Hyperkalemia Conditions	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.855	Medications_Chronic Hyperkalemia	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.858	PIM_Alpha_Blockers_2	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.860	PIM_Ambulatory_Visits_CPTs	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.862	PIM_Ambulatory_Visits_SNOMED	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.863	PIM_Thyroid_Stimulating_Hormone_(TSH)	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.864	PIM_Triiodothyronine_(T3)	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.865	PIM_Thyroxine_(T4)	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.866	PIM_Magnesium_LOINC	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.867	PIM_BMP_CMP_LOINC	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.868	PIM_URIC_ACID_LOINC	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.869	PIM_Migraine_Medications	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.870	PIM_Triptans	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.871	ICS_SABA Reliever	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.873	PIM_Asthma_COPD_Meds	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.874	PIM_Lipid_Panel_CPTs	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.875	PIM_Hepatic_Function_Panel_CPTs	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.876	Alpha Glucosidase Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.877	Inflammatory bowel disease I10	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.878	Inflammatory bowel disease SCT	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.879	Inflammatory bowel disease	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.880	Gastrointestinal obstruction SCT	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.881	Gastrointestinal obstruction I10	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.882	Gastrointestinal obstruction	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.883	DPP4i Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.884	Multiple endocrine neoplasia type 2 (MEN II) SCT	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.885	Multiple endocrine neoplasia type 2 (MEN II) I10	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.886	Multiple endocrine neoplasia type 2 (MEN II)	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.887	Gastroparesis SCT	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.888	Gastroparesis I10	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.889	Gastroparesis	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.890	Meglitinide Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.891	Sulfonylurea Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.892	Peripheral edema I10	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.893	Peripheral edema SCT	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.894	Peripheral edema	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.895	TZD Allergy Intolerance	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.896	PIM_Beta_Blockers	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.897	PIM_CCB_DHPs	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.898	PIM_Loop_Diuretics	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.899	PIM_Inhaled_Corticosteroids_(ICS)	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.9	ACE inhibitors	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.90	ASCVD I10	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.900	PIM_Leukotrienes	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.901	OIA_Asthma_COPD_Meds_Inhalers	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.902	OIA_Asthma_COPD_Meds_Nebulizers	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.903	OIA_Asthma_COPD_Meds_Oral	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.904	OIA_GLP1_Injectables	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.905	OIA_Insulin_Injectables	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.906	OIA_Oral_Hypoglycemics	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.907	OIA_DM1_DM2_Meds	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.908	Medium Dose ICS Formoterol	active	2024-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.909	High Dose ICS Formoterol	active	2024-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.910	CKD stage5OrESRD I10	active	2024-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.911	CKD stage5OrESRD SCT	active	2024-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.912	CKD stage5OrESRD	active	2024-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.914	Anxiety_I10	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.915	Anxiety_SCT	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.916	Anxiety	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.918	Stress_SCT	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.919	Stress_I10	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.920	Stress	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.921	PBH_Anxiety_SCT	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.922	PBH_Depression_SCT	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.923	PBH_Stress_SCT	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.924	PBH_Insomnia_SCT	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.925	PIM_CMP_CPTs	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.926	Canagliflozin meds	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.927	Empagliflozin meds	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.928	Dapagliflozin meds	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.929	Ertugliflozin meds	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.930	Dulaglutide meds	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.931	Liraglutide meds	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.932	Semaglutide SC meds	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.933	T2DM meds benefitting ASCVD	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.934	T2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/min	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.935	T2DM meds benefitting CKD stage 5	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.936	T2DM meds benefitting HF with eGFR >= 20 mL/min	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.938	Crohn disease SCT	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.939	Crohn disease I10	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.940	Crohn disease	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.941	Celiac disease SCT	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.942	Celiac disease I10	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.943	Celiac disease	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.944	OIA_Bisoprolol	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.945	OIA_PVD_ICD10	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.946	Vibration Controlled Transient Elastography (VCTE)	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.947	OIA_Antihypertensive_Medications	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.950	OIA_CAD_ICD10	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.951	OIA_DM_ICD10	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.952	OIA_Creatinine_Levels_LOINC	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.953	OIA_DM_SNOMEDCT	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.954	OIA_CAD_SNOMEDCT	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.955	OIA_PVD_SNOMEDCT	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.956	OIA_DM_ICD10_SNOMEDCT	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.957	OIA_CAD_ICD10_SNOMEDCT	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.958	OIA_PVD_ICD10_SNOMEDCT	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.959	ACEi for HFrEF	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.960	ARB for HFrEF	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.961	OIA_AntiHTN_Meds_Inclusion_List	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.962	OIA_Thiazide_Diuretics	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.963	OIA_RFs_ACS_ICD10	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.964	OIA_RFs_ACS_SNOMED	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.965	OIA_RFs_ACS__ICD10_SNOMED	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.966	OIA_Aortic_Calcifications_ICD10	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.967	OIA_Aortic_Calcifications_SNOMED	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.968	OIA_Aortic_Calcifications_ICD10_SNOMED	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.969	OIA_Microalbumin	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.97	Sulfonylurea AllergyIntolerance SCT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.970	OIA_LDL_Cholesterol	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.971	Pioglitazone	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.972	MASLD I10	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.973	MASLD SCT	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.975	OIA_Sulfonylureas	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.978	OIA_RFs_ASCVD_ICD10	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.979	OIA_RFs_ASCVD_SNOMED	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.98	BMI LOINC	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.980	OIA_RFs_ASCVD_ICD10_SNOMED	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.981	OIA_TIA_ICD10	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.982	OIA_TIA_SNOMED	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.983	OIA_TIA_ICD10_SNOMED	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.984	OIA_Angina_ICD10	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.985	OIA_Angina_SNOMED	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.987	OIA_Angina_ICD10_SNOMED	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.988	OIA_Ischemic_Hemorrhagic_Stroke_ICD10	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.989	OIA_Ischemic_Hemorrhagic_Stroke_SNOMED	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.990	OIA_Ischemic_Hemorrhagic_Stroke_ICD10_SNOMED	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.991	OIA_Myocardial_Infarction_ICD10	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.992	OIA_Myocardial_Infarction_SNOMED	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.993	OIA_Myocardial_Infarction_ICD10_SNOMED	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.995	OIA_PAD_ICD10	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.996	OIA_PAD_SNOMED	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.997	OIA_PAD_ICD10_SNOMED	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.998	OIA_Coronary_Arterial_Revascularization	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1080.5	Contact or Office Visit	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1080.6	Contact or Office Visit	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1080.7	Contact or Office Visit	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.10	Nutrition Diagnosis SNOMED CT	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.101	Hospice Status	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.14	Vitamin Mineral Supplement and Bioactive Substance Management SNOMED CT	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.17	Pediatric Enteral Formulas SNOMED CT	active	2021-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.18	Modified Amino Acid Formulas SNOMED CT	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.19	Nutrition Counseling Approach and Strategies SNOMED CT	active	2020-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.20	Enteral Nutrition Management SNOMED CT	active	2020-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.21	Nutrition Assessment	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.25	Nutritional Status Severely Malnourished	active	2016-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.30	Malnutrition Risk Screening	active	2015-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.31	Malnutrition At Risk	active	2015-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.32	Malnutrition Risk Screening	active	2016-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.34	Malnutrition Screening Finding of Not At Risk Result	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.35	Malnutrition Screening Not at Risk	active	2015-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.38	Malnutrition Screening Finding of At Risk Result	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.39	Malnutrition Risk Screening	active	2016-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.40	Malnutrition Risk Screening	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.41	Nutritional Status Severely Malnourished	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1095.42	Nutrition Assessment Status Finding of Severely Malnourished	active	2024-12	hl7